MarketPeel
Pricing
…
Chief R&D Officer
Jonathan Zalevsky
Mon, Aug 15, 2022
Aug 15
received an award in NKTR
135,000 shares @ $0.00
Increased holdings by +48.80%
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
NKTRNEKTAR THERAPEUTICS
Health CarePharmaceuticals
1D0.00%
1W+0.52%
1M+4.65%
3M+13.18%
6M—
1Y—

Recent insider activity at NKTR

Aug 18Jonathan ZalevskySold$13.39kAug 18Howard W. RobinSold$30.09kJun 30Jonathan ZalevskySold$397.67kJun 17Howard W. RobinSold$277.43kJun 17Howard W. RobinSold$334.45kJun 16Howard W. RobinSold$285.15kJun 16Howard W. RobinSold$318.02kJun 15Jonathan ZalevskySold$336.21k
Full NKTR profile →Jonathan Zalevsky’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback